Document Detail

A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286.
MedLine Citation:
PMID:  18624766     Owner:  NLM     Status:  In-Process    
Pharmacological GSK-3 inhibitors are potential drugs for the treatment of neurodegenerative diseases, cancer and diabetes. We examined the antiproliferative effects of two GSK-3 inhibitors, lithium and SB-415286, on B65 neuroblastoma cell line. Treatment of B65 cells with either drug administered separately caused a decrease in cell proliferation that was associated with G(2)/M cell cycle arrest. Cell-cycle proteins such as cyclins D, E, A, cdk4 and cdk2 were up-regulated. Since lithium and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2). Both drugs increased the expression of tyr15-cdc2, thus inhibiting mitosis. On the other hand, SB-415286 increased the expression of SIRT2, involved in the regulation of proliferation. Moreover, cell-cycle arrest mediated by SB-415286 was accompanied by apoptosis that was not prevented by 100 microM of zVAD-fmk (benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone), a pan-caspase inhibitor. Likewise, GSK-3 inhibitors did not affect the mitochondrial release of apoptosis inducing factor (AIF). We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of cdc2 and, in the case of SB-415286, SIRT2 expression, which induced apoptosis in a caspase-independent manner.
Javier G Pizarro; Jaume Folch; José Luis Esparza; J Jordan; Mercè Pallàs; Antoni Camins
Related Documents :
15007206 - Inhibitory function of whey acidic protein in the cell-cycle progression of mouse mamma...
12885576 - Cell cycle aberrations by alpha-synuclein over-expression and cyclin b immunoreactivity...
17560576 - Gsk-3beta mediates in the progesterone inhibition of estrogen induced cyclin d2 nuclear...
9367986 - Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inh...
23874226 - The btb-zinc finger transcription factor abrupt acts as an epithelial oncogene in droso...
9438176 - Effect of cyclosporine a on na+/k(+)-atpase, na+/k+/2cl- cotransporter, and h+/k(+)-atp...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-06-20
Journal Detail:
Title:  Journal of cellular and molecular medicine     Volume:  13     ISSN:  1582-4934     ISO Abbreviation:  J. Cell. Mol. Med.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2010-03-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101083777     Medline TA:  J Cell Mol Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  3906-17     Citation Subset:  IM    
Unitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Institut de Biomedicina and Centros de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Universitat de Barcelona, Nucli Universitari de Pedralbes, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellu...
Next Document:  Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanos...